Blue Faery: The Adrienne Wilson Liver Cancer Association will bring its free, in-person HCC Lunch & Learn to Chicago on October 24, 2026, offering critical education about liver health, liver disease, and hepatocellular carcinoma (HCC). The event, developed with liver cancer experts, is designed to help patients, caregivers, and individuals at risk for liver cancer better understand prevention, early detection, treatment options, and support resources.
The significance of this announcement lies in its direct response to a pressing public health need. Hepatocellular carcinoma is the most common form of primary liver cancer, and many of its major risk factors are tied to chronic liver disease. By increasing awareness of those risks and helping people recognize when screening and specialized care may be needed, Blue Faery aims to improve liver cancer outcomes—an urgent goal given that liver cancer often presents late, when treatment options are limited.
“Knowledge can change outcomes—everyone deserves clear, trusted information and support when facing liver cancer,” said Andrea Wilson Woods, Founder and President of Blue Faery. That philosophy drives the Lunch & Learn series, which supports the organization’s mission to prevent, treat, and cure primary liver cancer through education, advocacy, and support.
The event will run from 10:00 a.m. to 3:00 p.m. (doors open at 9:30 a.m.) at University of Chicago Medicine in the Knapp Center for Biomedical Discovery Auditorium, First Floor, Room 1103. The free event includes a catered lunch and complimentary parking with validation; attendees must bring their parking ticket inside for validation. Due to the serious nature of the topics discussed, attendees must be at least 16 years old, and each attendee must register separately. Space is limited, and advance registration is encouraged.
Topics on the agenda include liver disease and HCC risk factors and symptoms, prevention and early detection of liver cancer, current treatment options for HCC, the importance of multidisciplinary care, and resources and support for patients and caregivers. These subjects reflect a growing recognition that managing liver cancer effectively requires not only medical intervention but also patient empowerment and coordinated care across specialties.
For those unable to attend in person, Blue Faery offers ongoing support through its online Liver Cancer Community for patients and caregivers. The organization also provides free comprehensive patient education with its Patient Resource Guides for Liver Cancer. In addition to the HCC Lunch & Learn, Blue Faery runs programs such as Love Your Liver, The Truth About Liver Cancer, and You and Liver Cancer. To learn more and register for the Chicago event, visit https://www.bluefaery.org/hcc-lunch-learn.
By bringing expert-led education directly to the community, Blue Faery hopes to reduce the information gaps that can delay diagnosis and hinder access to care. The Chicago event represents a tangible step toward that goal, equipping attendees with knowledge that could ultimately save lives.
